New discovery by Polish doctors: a breakthrough in the diagnosis of a rare genetic disease
A team of Polish specialists has published the results of research into a rare genetic disorder known as hereditary hemorrhagic telangiectasia (HHT). This disease often leads to serious complications, which is why understanding its genetic basis is crucial for effective treatment of patients in Poland and around the world.
Scientists identified a new mutation in the ACVRL1 gene in a patient who simultaneously presented with pulmonary hypertension. This is a significant discovery, as mutations in this specific gene are known to cause more severe liver lesions and an increased risk of developing pulmonary circulation problems.
This study highlights the importance of precise genetic diagnostics in modern medicine. By detecting a specific change in DNA, doctors can better predict the course of the disease in a given patient and implement appropriate therapy more quickly, which directly translates into improving the patients' quality of life.
The publication in the journal "Medycyna Praktyczna" represents an important step toward a better understanding of the mechanisms of rare diseases. Doctors hope that through further research into genetic mutations, the diagnosis of such conditions will become faster and more accessible to all patients in need in the future.